A recent meta-analysis concluded that newer antidepressant drugs are equivalent to or no better than placebos, a conclusion at some variance with their commonly judged clinical effectiveness. The 'disconnect' between randomised controlled trials and clinical practice would benefit from dissection of contributing factors, and redressing limitations to current trial procedures.
No takes yet. Share an insight, caveat, or question.
Gordon Parker (2008) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: